BioPharma Credit BOPCF Stock
$0.96
-5.882353%
Add to favorites
COUNTRY
Exchange
Market Cap
$0.00
LOW - HIGH [24H]
$0.96
-
$0.96
VOLUME [24H]
$7.00K
P/E Ratio
15.48
Earnings per share
$0.06
BioPharma Credit Price Chart
BioPharma Credit BOPCF Financial and Trading Overview
| BioPharma Credit stock price | 0.96 USD |
| Previous Close | 1.02 USD |
| Open | 0.96 USD |
| Bid | 0.9 USD x 200000 |
| Ask | 1.02 USD x 20000 |
| Day's Range | 0.96 - 0.96 USD |
| 52 Week Range | 0.84 - 1.02 USD |
| Volume | 7K USD |
| Avg. Volume | 382.6K USD |
| Market Cap | N/A |
| Beta (5Y Monthly) | 0.172 |
| PE Ratio (TTM) | 15.4838705 |
| EPS (TTM) | 0.06 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
BOPCF Valuation Measures
| Enterprise Value | 1.07B USD |
| Trailing P/E | 15.4838705 |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 0.94210005 |
| Enterprise Value/Revenue | 6.792 |
| Enterprise Value/EBITDA | N/A |
Trading Information
BioPharma Credit Stock Price History
| Beta (5Y Monthly) | 0.172 |
| 52-Week Change | 2.43% |
| S&P500 52-Week Change | 27.18% |
| 52 Week High | 1.02 USD |
| 52 Week Low | 0.84 USD |
| 50-Day Moving Average | 0.92 USD |
| 200-Day Moving Average | 0.92 USD |
BOPCF Share Statistics
| Avg. Volume (3 month) | 382.6K USD |
| Avg. Daily Volume (10-Days) | 353.96K USD |
| Shares Outstanding | 914.25M |
| Float | 1.13B |
| Short Ratio | N/A |
| % Held by Insiders | 6.55% |
| % Held by Institutions | 54.54% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0.07 |
| Trailing Annual Dividend Yield | 6.86% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | N/A |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | December 31, 2025 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | 82.33% |
| Operating Margin (ttm) | 77.18% |
| Gross Margin | 100.00% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | 6.85% |
| Return on Equity (ttm) | 11.13% |
Income Statement
| Revenue (ttm) | 157.75M USD |
| Revenue Per Share (ttm) | 0.14 USD |
| Quarterly Revenue Growth (yoy) | 4.29% |
| Gross Profit (ttm) | 157.75M USD |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | 129.89M USD |
| Diluted EPS (ttm) | 0.062 |
| Quarterly Earnings Growth (yoy) | 13.40% |
Balance Sheet
| Total Cash (mrq) | 12.59M USD |
| Total Cash Per Share (mrq) | 0.01 USD |
| Total Debt (mrq) | 0 USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 3.77 |
| Book Value Per Share (mrq) | 1.019 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 91.1M USD |
| Levered Free Cash Flow (ttm) | 59.03M USD |
Profile of BioPharma Credit
| Country | United States |
| State | N/A |
| City | London |
| Address | 51 Lime Street |
| ZIP | EC3M 7DQ |
| Phone | N/A |
| Website | https://www.bpcruk.com |
| Industry | |
| Sector(s) | |
| Full Time Employees | N/A |
BioPharma Credit PLC, an investment trust, primarily invests in interest-bearing debt assets. Its debt assets are secured by royalties or other cash flows derived from the sales of approved life sciences products. BioPharma Credit PLC was incorporated in 2016 and is based in London, the United Kingdom.
Q&A For BioPharma Credit Stock
What is a current BOPCF stock price?
BioPharma Credit BOPCF stock price today per share is 0.96 USD.
How to purchase BioPharma Credit stock?
You can buy BOPCF shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for BioPharma Credit?
The stock symbol or ticker of BioPharma Credit is BOPCF.
How many shares does BioPharma Credit have in circulation?
The max supply of BioPharma Credit shares is 0.
What is BioPharma Credit Price to Earnings Ratio (PE Ratio)?
BioPharma Credit PE Ratio is 15.48387050 now.
What was BioPharma Credit earnings per share over the trailing 12 months (TTM)?
BioPharma Credit EPS is 0.06 USD over the trailing 12 months.